Sector
PharmaceuticalsOpen
₹27.24Prev. Close
₹25.95Turnover(Lac.)
₹3.26Day's High
₹27.24Day's Low
₹27.2452 Week's High
₹43.8452 Week's Low
₹23.55Book Value
₹19.79Face Value
₹10Mkt Cap (₹ Cr.)
5.72P/E
112.83EPS
0.23Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 2.1 | 2.1 | 2.1 | 1.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2.06 | 2.01 | 2 | 0.1 |
Net Worth | 4.16 | 4.11 | 4.1 | 1.3 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Revenue | 3.05 | 7.51 | 2.76 |
yoy growth (%) | -59.32 | 172.18 | |
Raw materials | -2.73 | -6.88 | -1.82 |
As % of sales | 89.36 | 91.65 | 66.03 |
Employee costs | -0.14 | -0.2 | -0.3 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Profit before tax | 0.04 | 0.09 | 0 |
Depreciation | -0.01 | -0.01 | -0.02 |
Tax paid | -0.01 | -0.03 | 0 |
Working capital | 0.23 | -1.4 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -59.32 | 172.18 | |
Op profit growth | -80.11 | -0.31 | |
EBIT growth | -83.67 | 2.37 | |
Net profit growth | -56.16 | 68,800 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
---|---|---|
Gross Sales | 21.08 | 3.36 |
Excise Duty | 0 | 0 |
Net Sales | 21.08 | 3.36 |
Other Operating Income | 0 | 0 |
Other Income | 0.01 | 0.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,823.35 | 157.3 | 4,37,806.65 | 237.82 | 0.74 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,140.8 | 81.93 | 1,36,080.52 | 430 | 0.58 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,611.9 | 33.1 | 1,31,478.83 | 1,055.94 | 0.8 | 3,752.25 | 346.4 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,417 | 77.52 | 1,16,513.07 | 469 | 0.81 | 2,394 | 201.77 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,100.5 | 25.69 | 1,12,205.15 | 1,700.8 | 0.27 | 4,035.4 | 156.19 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Aditya Mahavir Jain
Non Executive Director
Arihant Jain
Independent Non Exe. Director
Tesu Alakh
Non-Exec & Non-Independent Dir
Sumit Malik
Additional Director
Satender Jain
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Fabino Life Sciences Ltd
Summary
Fabino Life Sciences is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as Fabino Life Sciences Private Limited on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to Fabino Life Sciences Limited vide Special Resolution dated March 03, 2015. A fresh Certificate of Incorporation consequent to conversion was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other wellness focused consumer products like, packing, trading, etc. The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. The Company export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by Company. The Company operate a manufacturing plant at Sonipat, Haryana. The Company manufactures and pack products and market approximately 70+ products in the domestic market and have a portfolio of FMCG products for Overseas Markets. These products are being marketed under the respective trademarks and brands like Fabino and Keepshine. Fabino brand market mostly all pharmaceutica
Read More
The Fabino Enterprises Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹27.24 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fabino Enterprises Ltd is ₹5.72 Cr. as of 06 Sep ‘24
The PE and PB ratios of Fabino Enterprises Ltd is 112.83 and 1.31 as of 06 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Fabino Enterprises Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fabino Enterprises Ltd is ₹23.55 and ₹43.84 as of 06 Sep ‘24
Fabino Enterprises Ltd's CAGR for 5 Years at N/I%, 3 Years at -13.68%, 1 Year at -12.33%, 6 Month at -30.98%, 3 Month at -4.77% and 1 Month at -7.98%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice